9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3962 | TPI-1 | TPI 1,TPI1 | Phosphatase , Glucocorticoid Receptor |
TPI-1 is a SHP-1 inhibitor. | |||
T34910 | TPI-1917-49 | TPI 1917 49 | |
TPI-1917-49 is a promising amyloid reducing agent that works by reducing Aβ levels. | |||
T68570 | TPI-287 | ||
TPI 287 is a synthetic, third generation taxane with potential antineoplastic activity. TPI 287 binds to tubulin and stabilizes microtubules, resulting in inhibition of microtubule assembly/disassembly dynamics, cell cyc... | |||
T8673 | FMOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CAR | Fmoc-Tpi-OH | Others |
FMOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CAR (Fmoc-Tpi-OH) is a derivative of THN. | |||
T8140 | Tianeptine | S-1574,JNJ-39823277,Tianeptine sodium,TPI-1062 | 5-HT Receptor |
Tianeptine (Tianeptine sodium) is a selective 5-HT uptake facilitator in vitro and in vivo. | |||
T3658 | Trifluridine/tipiracil hydrochloride mixture | Trifluridine-tipiracil hydrochloride mixture,TAS102,TAS-102,TAS 102 | Nucleoside Antimetabolite/Analog , DNA/RNA Synthesis |
Trifluridine/tipiracil hydrochloride mixture (TAS-102) is a novel oral combination drug containing trifluridine (TFT) and Tipiracil hydrochloride (TTP) in a molar ratio of 2:1. | |||
T8732 | CTPI-2 | Others , Mitochondrial Metabolism | |
CTPI-2 is an inhibitor of mitochondrial citrate carrier SLC25A1 with(KD : 3.5 μM). CTPI-2 inhibits glycolysis, PPARγ, and its downstream target the glucose transporter GLUT4. CTPI-2 exhibits anti-tumor activity.CTPI-2 ha... | |||
T2366 | Tipiracil hydrochloride | MA-1 hydrochloride | Nucleoside Antimetabolite/Analog |
Tipiracil hydrochloride (MA-1 hydrochloride) is a thymidine phosphorylase inhibitor (TPI). Tipiracil hydrochloride is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical t... | |||
T76154 | Triosephosphate isomerase | ||
Triosephosphate isomerase (TPI), a glycolytic enzyme, efficiently catalyzes the interconversion between dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate. The catalytic site of TPI is located at the dimer inter... |